Business Wire

Spirent Supports New H3C in Industry’s Highest Density 100 Gigabit Ethernet Data Center Switch Performance Test

Del

Spirent Communications, Plc (LSE: SPT), the industry leader in Ethernet test and measurement, announced today the successful support of New H3C in the industry’s highest density 100G data center switch test ever conducted. The test, completed by Spirent Communications and the New H3C Group and moderated by independent test lab Network Test, tested the line-rate forwarding capacity and hyper-scale IP route announcement capacity of the H3C S12500X-AF chassis full of 100G ports with a density of 768 100G ports per chassis.

According to David Newman of Network Test, “With 768 ports, this is the largest 100G Ethernet switch test successfully completed in the industry so far. The stress tests we conducted involved nearly 1 million unique BGP routes as well as 768 concurrent EVPN instances within a single chassis. These benchmarks, based on open testing standards, successfully verified New H3C data center core switches, with Spirent TestCenter providing the high density, high performance, and high flexibility required for this record-breaking project.”

The test was conducted using Spirent TestCenter® and the Spirent N11U chassis, Spirent’s flagship network performance test solution. The Spirent N11U chassis included the high density dX3 12-port 100G test modules capable of verifying next-generation data center architectures and routers. Spirent TestCenter generated 100G line-rate transaction traffic of various frame lengths, and provided packet loss, latency, jitter, frame sequence, code errors and FCS error analytics to reflect the quality of transmission in real time.

“The S12500X-AF series of switches provide a maximum of 48 100G QSFP28 pluggable optical modules per slot, which is the highest density in the world, with New H3C being the only vendor in the industry to provide full line-rate 768 100G ports for datacenter core switches,” said Steven Yoe, Senior Vice President and CTO of the New H3C Group. “We were pleased to work with Spirent to verify the performance of S12500X-AF and achieve satisfactory test results.”

“Generation after generation of Spirent Ethernet testing technologies have helped our customers take advantage of market opportunities. We appreciate New H3C Group for selecting Spirent as a trusted testing partner for verifying the performance of its S12500X-AF series of switches” said Eric Hutchinson, CEO of Spirent Communications.

The Spirent dX3 quint-speed test module supports twelve 100G or 40G ports per slot, or twenty five 50G ports, or forty eight 25G or 10G ports per slot. It also supports key interface features such as FEC, Auto-negotiation and Link Training. It can be used to verify data plane Quality of Service (QoS) for hyper-dense network devices at line-rate, and to test complex routing, data center and access protocols on switches and routers.

Click here to download the test report.

For more information on Spirent TestCenter and the dX3 module, please visit http://www.spirent.comn/Products/TestCenter.

About Spirent Communications plc

Spirent Communications plc. (LSE: SPT) is the leading provider of verification, assessment, analytics, and device intelligence solutions. We enable those who deliver networks, connected devices, and communication services to provide a superior user experience. From service provider networks and enterprise datacenters to mobile communications and connected vehicles, Spirent works with leading innovators to help the world communicate and collaborate faster, better, and more securely. For more information visit: http://www.spirent.com/About-Us/News_Room.

About H3C

New H3C Group (New H3C) is a world-leading provider of New IT solutions. It is fully committed to the research & development, production, sales, consulting and services of New IT products and solutions. Providing customers with a full range of servers, storage, networking, security products, hyper-converged infrastructure and IT management systems under the H3C® brand, New H3C also offer customers a one-stop, complete portfolio of IT solutions and consulting services that includes Big Internet, Big Security, Cloud Computing and Big Data. In addition, New H3C is also the exclusive provider of HPE® branded Servers and Storage products as well as Technical Services in China.

Contact information

Americas
SSPR
John Nelson, +1 312-750-9081
spirent@sspr.com
or
Asia Pacific
Spirent Communications
Janet Peng, +86 (10) 82330055 x160
janet.peng@spirent.com
or
Europe
Spirent Communications
Simon Loe, +44 (0) 7850 205885
simon.loe@spirent.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

New Data Show Benefit of Tagrisso in Patients with EGFR-mutated Non-small Cell Lung Cancer and Central Nervous System Metastases18.11.2017 23:00Pressemelding

AstraZeneca today presented new data from a subgroup analysis of the Phase III FLAURA trial, which explored osimertinib as 1st-line therapy in patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC). Results presented at the ESMO Asia 2017 Congress in Singapore showed that patients with central nervous system (CNS) metastases at baseline had a higher objective response rate with their brain metastasis and suggest a lower risk of CNS progression when treated with osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), versus current standard-of-care EGFR-TKIs (erlotinib or gefitinib) [Abstract LBA5].1 The analysis included patients with ≥1 measurable and/or non-measurable CNS lesion present on baseline scan (as assessed by blinded independent central review), accounting for 23

New England Journal of Medicine Publishes Results of Phase III FLAURA Trial in the 1st-Line Treatment of EGFR-mutated Non-small Cell Lung Cancer18.11.2017 18:20Pressemelding

AstraZeneca today announced that the New England Journal of Medicine has published the positive results from the Phase III FLAURA trial which provide data for Tagrisso’s (osimertinib) use in the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).1 The trial showed a statistically significant, clinically meaningful progression-free survival (PFS) advantage for osimertinib, a third-generation, irreversible EGFR tyrosine kinase inhibitor (TKI), compared with current 1st-line EGFR-TKIs, erlotinib or gefitinib.1 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171118005044/en/ Dr. Suresh S. Ramalingam, Principal Investigator of the FLAURA trial, from the Winship Cancer Institute

Much-Anticipated CHTF 2017 Top 10 Products Are Unveiled18.11.2017 09:11Pressemelding

The 19th China Hi-Tech Fair (CHTF 2017), with the theme of “Innovation-Driven Development and Supply Quality Upgrade”, is taking place from November 16 to 21 at Shenzhen Convention and Exhibition Center. On the afternoon of November 10, the CHTF 2017 Top 10 Products were unveiled at the awards ceremony by Mr. Gao Zimin, Vice Mayor of Shenzhen City. A total of 322 entries competed for the honor Top 10 Products, and the voting lasted nearly 3 months. 60 candidate products in the fields of new energy, 3D print, flexible display, life sciences, unmanned vehicles and AI were shortlisted by the organizer, experts and media representatives and went for open voting online. The final Top 10 Products all represent the most advanced technologies in their respective sectors: the water-making device that can make water out of air, the smart sportswear that can monitor heartbeat and other

Madison Realty Capital Provides $64.0 Million Construction Financing for 200 Kent Avenue Development in Williamsburg, Brooklyn17.11.2017 16:20Pressemelding

Madison Realty Capital (MRC) announced the closing of a $64.0 million construction loan for 200 Kent Avenue, a 117,326 square foot mixed-use development located in Williamsburg, Brooklyn. The retail portion of the property, which will include over 600 feet of frontage, will be anchored by a popular national grocery chain. Overall, the project will offer 50,101 square feet of retail space, 22,055 square feet of office and restaurant space, and 45,170 square feet of parking. “We continue to establish MRC as the one-stop shop for financing transitional real estate, including ground-up development deals like 200 Kent Avenue,” said Josh Zegen, Co-Founder and Managing Principal of MRC. “In this case, we’re working with a repeat MRC borrower who understands our ability to execute efficiently, given our firm’s up-to-the minute knowledge of local market conditions and non-bureaucratic approach to

Ncardia Announces Completion of €10.5M Investment Round17.11.2017 12:31Pressemelding

Ncardia, an emerging drug discovery and development stem cell technology company whose mission is to deliver cardiac and neural solutions based on its best-in-class human induced pluripotent stem cell (iPSC)-derived technology, today announced the completion of a €10.5 million series B financing round. The round was led by Épimède, a Belgium venture capital firm. Ncardia is a privately-held company with operations in Europe and the US, that produces and commercializes high-quality, fully-functional human iPSC-derived cardiovascular and neuronal cell types. Using its cell products, Ncardia develops and commercializes assay services for drug safety and efficacy testing. Additionally the company has built up a strong portfolio of patents covering the use of stem cell models for these applications. Stefan Braam, CEO of Ncardia, commented: “At Ncardia, important progress h

Double Win for Vocalink at the 2017 Payments Awards17.11.2017 09:35Pressemelding

Vocalink, a Mastercard company, was last night awarded with two prestigious awards - The Overall Winner and the Payments Infrastructure of the Year Award, for its leading technology and expertise, and in recognition for a milestone year that saw Vocalink’s solutions transform the way people and businesses move money across the globe. 2017 saw Vocalink deliver ground-breaking immediate payments solutions both in the US and Thailand as well as enabling access to the UK payments industry through their payments gateway solution PayPort. The business also saw the launch of the new image based cheque clearing system, creating a robust and more efficient system in the UK. RTP ® in the US: This week, Vocalink announced the launch of RTP® (Real-Time Payments) in the US on behalf of The Clearing House; one of the most comprehensive real-tim

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom